调节性T细胞与急性冠状动脉综合征关系的研究进展
DOI:
作者:
作者单位:

(1.山西医科大学,山西省太原市 030000;2.山西医科大学第二医院心内科,山西省太原市 030000)

作者简介:

苏畅,硕士研究生,研究方向为冠心病的基础与临床,E-mail为1030330264@qq.com。通信作者边云飞,主任医师,教授,博士研究生导师,研究方向为冠心病的基础与临床,E-mail为yunfeibian@sina.com。

通讯作者:

基金项目:


Research progress on the relationship between regulatory T cells and acute coronary syndrome
Author:
Affiliation:

1.Shanxi Medical University, ;2.Department of Cardiology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    急性冠状动脉综合征(ACS)是一种以动脉粥样硬化斑块破裂为主要病理表现的临床综合征,炎症反应在这一过程中发挥着重要的作用,各种免疫细胞及细胞因子、炎症介质共同参与并推动炎症反应的发生发展。近年来文献报道,调节性T细胞(Treg)是一种特殊的能够负性调节免疫作用的CD4+T细胞,其在人体内的数量及比例对类风湿关节炎、强制性脊柱炎、系统性红斑狼疮等自身免疫性疾病的发生、发展有一定的影响。目前多数相关研究证实了Treg与ACS具有相关性。本文将围绕Treg的来源、生物学特性及Treg与ACS的关系、可能存在的机制进行综述。

    Abstract:

    Acute coronary syndrome (ACS) is a clinical syndrome with atherosclerotic plaque rupture as its main pathological manifestation. Inflammatory response plays an important role in this process. Various immune cells, cytokines and inflammatory mediators participate in and promote the occurrence and development of inflammatory response. In recent years, it has been reported that regulatory T cell (Treg) is a kind of special CD4+ T cell which can negatively regulate immune function. The number and proportion of Treg in human body have a certain impact on the occurrence and development of autoimmune diseases such as rheumatoid arthritis, mandatory spondylitis and systemic lupus erythematosus. At present, most related studies have confirmed the correlation between Treg and ACS. This review will focus on the origin, biological characteristics of Treg, the relationship between Treg and ACS, and the possible mechanism.

    参考文献
    相似文献
    引证文献
引用本文

苏畅,边云飞,程琳.调节性T细胞与急性冠状动脉综合征关系的研究进展[J].中国动脉硬化杂志,2021,29(5):456~460.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2020-02-22
  • 最后修改日期:2020-05-04
  • 录用日期:
  • 在线发布日期: 2021-04-23